Vascular lesions in genital lichen sclerosus in pediatric patients.


Journal

Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 19 02 2020
revised: 10 06 2020
accepted: 13 06 2020
pubmed: 9 7 2020
medline: 15 5 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

Lichen sclerosus is a rare, pruritic, mucocutaneous disease affecting mostly the anogenital area. Reports have occasionally associated lichen sclerosus with overlapping vascular lesions. This study explores this association in children. A retrospective study was conducted in the dermatology unit of a pediatric tertiary care medical center. Electronic medical records were searched for patients diagnosed with lichen sclerosus from 2006 to 2019. Review of the cases was performed to identify overlapping vascular lesions and review the clinical course of overlap cases. Of 74 children diagnosed with lichen sclerosus during the study period, five (6.75%) had overlapping vascular lesions and genital lichen sclerosus. Four patients presented with reticular telangiectatic macules and patches (n = 4, 5.4%) that appeared at or shortly after disease onset; resolution occurred a few months after treatment initiation. The fifth patient presented with telangiectases that appeared more than 2 years after the onset of the first symptoms of lichen sclerosus (n = 1, 1.3%). Vascular lesions in children with genital lichen sclerosus are common and have variable clinical manifestations. Early appearance of reticular macules, patches, and papules is a variant of the disease and is followed by prompt resolution of these lesions. Pathogenesis is attributed to structural changes and repositioning of the papillary vascular plexus. These changes may be alarming to parents and therefore must be recognized by physicians to prevent unnecessary concern and investigations.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Lichen sclerosus is a rare, pruritic, mucocutaneous disease affecting mostly the anogenital area. Reports have occasionally associated lichen sclerosus with overlapping vascular lesions. This study explores this association in children.
METHODS METHODS
A retrospective study was conducted in the dermatology unit of a pediatric tertiary care medical center. Electronic medical records were searched for patients diagnosed with lichen sclerosus from 2006 to 2019. Review of the cases was performed to identify overlapping vascular lesions and review the clinical course of overlap cases.
RESULTS RESULTS
Of 74 children diagnosed with lichen sclerosus during the study period, five (6.75%) had overlapping vascular lesions and genital lichen sclerosus. Four patients presented with reticular telangiectatic macules and patches (n = 4, 5.4%) that appeared at or shortly after disease onset; resolution occurred a few months after treatment initiation. The fifth patient presented with telangiectases that appeared more than 2 years after the onset of the first symptoms of lichen sclerosus (n = 1, 1.3%).
CONCLUSION CONCLUSIONS
Vascular lesions in children with genital lichen sclerosus are common and have variable clinical manifestations. Early appearance of reticular macules, patches, and papules is a variant of the disease and is followed by prompt resolution of these lesions. Pathogenesis is attributed to structural changes and repositioning of the papillary vascular plexus. These changes may be alarming to parents and therefore must be recognized by physicians to prevent unnecessary concern and investigations.

Identifiants

pubmed: 32638397
doi: 10.1111/pde.14277
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

849-852

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Tong LX, Sun GS, Teng JM. Pediatric lichen sclerosus: a review of the epidemiology and treatment options. Pediatr Dermatol. 2015;32(5):593-599.
Lee A, Fischer G. Diagnosis and treatment of vulvar lichen sclerosus: an update for dermatologists. Am J Clin Dermatol. 2018;19(5):695-706.
Kim CY, Kim JG, Oh CW. Treatment of oral lichen sclerosus with 0.1% pimecrolimus cream. Ann Dermatol. 2010;22(3):326-329.
Shiver M, Papasakelariou C, Brown JA, Wirges M, Kincannon J. Extragenital bullous lichen sclerosus in a pediatric patient: a case report and literature review. Pediatr Dermatol. 2014;31(3):383-385.
Luzar B, Neil SM, Calonje E. Angiokeratoma-like changes in extragenital and genital lichen sclerosus. J Cutan Pathol. 2009;36(5):540-542.
Vash-Margita A, Smith YR, Rabah R, Quint EH. Adolescent vulvar angiokeratoma associated with lichen sclerosus. J Pediatr Adolesc Gynecol. 2019;32(4):440-442.
Knio Z, Kurban M, Abbas O. Lichen sclerosis: clinicopathological study of 60 cases from Lebanon. Int J Dermatol. 2016;55(10):1076-1081.
Kowalewski C, Kozłowska A, Górska M, et al. Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus. Am J Dermatopathol. 2005;27(6):489-496.
Pope E, Laxer RM. Diagnosis and management of morphea and lichen sclerosus and atrophicus in children. Pediatr Clin North Am. 2014;61(2):309-319.

Auteurs

Rivka Friedland (R)

Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Dan Ben-Amitai (D)

Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Elena Didkovsky (E)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Pathology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Meora Feinmesser (M)

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Institute of Pathology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.

Alex Zvulunov (A)

Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Faculty of Health Sciences, BenGurion University of the Negev, Beer Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH